Searchable abstracts of presentations at key conferences in endocrinology

ea0050cmw4.2 | Workshop 4: Graves orbitopathy: a Thyronet/ TEAMED | SFEBES2017

Molecular mechanisms of Graves’ Orbitopathy

Draman Mohd Shazli

Graves’ orbitopathy (GO) or thyroid eye disease (TED) is an autoimmune condition most common in people with hyperthyroid Graves’ disease. Severe GO may cause blindness due to optic compression following expansion of the orbital contents. In many patients, the persistent disfigured appearance of the eyes is a source of significant psychological distress and effective treatments are lacking. This has driven efforts to identify novel therapeutic options resulting in pro...

ea0050cmw4.2 | Workshop 4: Graves orbitopathy: a Thyronet/ TEAMED | SFEBES2017

Molecular mechanisms of Graves’ Orbitopathy

Draman Mohd Shazli

Graves’ orbitopathy (GO) or thyroid eye disease (TED) is an autoimmune condition most common in people with hyperthyroid Graves’ disease. Severe GO may cause blindness due to optic compression following expansion of the orbital contents. In many patients, the persistent disfigured appearance of the eyes is a source of significant psychological distress and effective treatments are lacking. This has driven efforts to identify novel therapeutic options resulting in pro...

ea0015p230 | Pituitary | SFEBES2008

Spontaneous recovery from severe cardiac failure after acute hypotensive infarction of a somatotroph adenoma

Moran Carla , Davenport Colin , Behan Lucy Ann , Draman Mohd Shazli , King Thomas , Sreenan Seamus , Thompson Christopher , Agha Amar

Acromegalic congestive cardiac failure (CCF) is a serious and late complication of untreated acromegaly with associated high morbidity and mortality.1 Spontaneous recovery of end stage acromegalic CCF following autoinfarction of a somatotroph adenoma has not been previously reported.We report the case of a 61-year-old woman who presented with features of severe biventricular CCF and an acromegalic phenotype. Echocardiography revealed poor LV f...

ea0013p241 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

Late development of secondary resistance to cabergoline in a patient with a lactotroph adenoma

Draman Mohd Shazli , Moran Carla , King Tom , Crowley Rachel , O’Sullivan Eoin , Smith Diarmuid , Thompson Christopher , Agha Amar

Primary resistance to Cabergoline occurs in a minority of patients with lactotroph adenomas but the development of late resistance following initial response is an extremely rare phenomenon which has only been reported in very few cases.: We report the case of a 57 year old lady who was presented in 1997 with headaches and visual failure and was found to have a large pituitary mass with compression of the optic chiasm and invasion into the cavernous sinuses bilaterally. Serum ...

ea0050p399 | Thyroid | SFEBES2017

Autoantibodies to the thyrotropin receptor in Alemtuzumab-induced thyroid autoimmunity: determination of their biological activity, and possible role as predictive marker of disease

Muller Ilaria , Willis Mark , Healy Sarah , Nasser Taha , Zhang Lei , Draman Mohd Shazli , Taylor Peter , Robertson Neil , Ludgate Marian , Dayan Colin

Background: Alemtuzumab (ALTZ) is a humanised monoclonal anti-CD52 antibody used as effective treatment for relapsing/remitting multiple sclerosis (MS), causing panlymphopenia with subsequent lymphocyte repopulation. Unfortunately, around 40% of patients develop secondary humoral autoimmunity, mainly affecting the thyroid gland. Anti-thyrotropin-receptor (TSHR) autoantibodies (TRAb) can stimulate (TSAb), block (TBAb) or not affect (‘neutral’) TSHR function, with TSAb...

ea0050p399 | Thyroid | SFEBES2017

Autoantibodies to the thyrotropin receptor in Alemtuzumab-induced thyroid autoimmunity: determination of their biological activity, and possible role as predictive marker of disease

Muller Ilaria , Willis Mark , Healy Sarah , Nasser Taha , Zhang Lei , Draman Mohd Shazli , Taylor Peter , Robertson Neil , Ludgate Marian , Dayan Colin

Background: Alemtuzumab (ALTZ) is a humanised monoclonal anti-CD52 antibody used as effective treatment for relapsing/remitting multiple sclerosis (MS), causing panlymphopenia with subsequent lymphocyte repopulation. Unfortunately, around 40% of patients develop secondary humoral autoimmunity, mainly affecting the thyroid gland. Anti-thyrotropin-receptor (TSHR) autoantibodies (TRAb) can stimulate (TSAb), block (TBAb) or not affect (‘neutral’) TSHR function, with TSAb...

ea0049ep1342 | Thyroid (non-cancer) | ECE2017

Immune reaction to food antigens in Graves’disease (GD) patients: role of gliadin and other food antigens

Covelli Danila , Colucci Giuseppe , Salvi Mario , Kaiser Ulrike , Eckstein Anja , Burlacu Maria Cristina , Daumerie Chantal , Richell Gez , Perros Petros , Draman Mohd Shazli , Ludgate Marian , Masetti Giulia , Biscarini Filippo

As known, an imbalance of the gut microbiota is associated with a higher risk for autoimmune diseases. Moreover the increased rates of autoimmunity reported in urban residential areas worldwide suggest a possible influence of diet. We report on the antibody response to food antigens in GD patients. Since 10% of celiac patients develop an autoimmune thyreopathy we focused on gliadin (DGP), transglutaminases (tTG) and 40 other food antigens (FA). Commercially available ELISA ass...

ea0063gp179 | Benign Thyroid Disorders | ECE2019

Long-term cardiometabolic effects of maternal sub-optimal gestational thyroid function and relative treatment in the Controlled Antenatal Thyroid Screening (CATS) study II

Muller Ilaria , Taylor Peter , Daniel Rhian , Hales Charlotte , Scholz Anna , Yin Xiaochen , Candler Toby , Pettit Rebecca , Evans William , Shillabeer Dionne , Draman Mohd , Dayan Colin , Tang Carolyn , Okosieme Onyebuchi , Gregory John , Lazarus John , Rees Aled , Ludgate Marian

Introduction: The effects of maternal suboptimal gestational thyroid function (SGTF) on age 3 offspring’s cognitive function were investigated in the Controlled Antenatal Thyroid Screening (CATS) randomised trial, comparing SGTF mothers who received (SGTF-T), or didn’t (SGTF-U), levothyroxine during pregnancy. The analysis was repeated at age 9 in the CATS-II follow-up study, also including children of mothers with normal gestational thyroid function (NGTF). Here we ...

ea0044oc6.3 | Pregnancy and Reproductive Health | SFEBES2016

Controlled Antenatal Thyroid Screening Study; Obstetric Outcomes

Taylor Peter , Lacey Arron , Thayer Daniel , Draman Mohd , Tabasum Arshiya , Muller Ilaria , Marsh Luke , Poacher Arwel , Roberts Aled , Ludgate Marian , Rees Alex , Boelaert Kristien , Rees Aled , Chan Shiao , Lazarus John , Nelson Scott , Vaidya Bijay , Okosieme Onyebuchi

Context: Suboptimal thyroid function in pregnancy is associated with adverse obstetric outcomes but it is unclear whether levothyroxine treatment, initiated during pregnancy is beneficial.Design & Participants: Retrospective analysis of the Controlled Antenatal Thyroid Screening (CATS) study with obstetric outcomes obtained through data-linkage in the Secure Anonymised Information Linkage (SAIL) databank. We studied 13,224 pregnant women; 12,608 had ...

ea0059p200 | Thyroid | SFEBES2018

Controlled Antenatal Thyroid Screening (CATS) II: long-term cardiometabolic effects of treating maternal sub-optimal thyroid function

Muller Ilaria , Daniel Rhian , Hales Charlotte , Scholz Anna , Yin Xiaochen , Candler Toby , Pettit Rebecca , Evans William , Taylor Peter , Shillabeer Dionne , Draman Mohd , Dayan Colin , Tang Carolyn , Okosieme Onyebuchi , Gregory John , Lazarus John , Rees Aled , Ludgate Marian

Objectives: The Controlled Antenatal Thyroid Screening (CATS) study I was a randomised trial investigating the effects of levothyroxine treatment for suboptimal gestational thyroid function (SGTF), evaluating mothers with normal gestational thyroid function (NGTF), SGTF who received (SGTF-T), or didn’t (SGTF-U), levothyroxine during pregnancy. The present follow-up study (CATS II) reports the long-term effects of SGTF and levothyroxine treatment on anthropometric and card...